SHIRLANN KNIGHT: Open Payments
NPI 1982810198 · SPRINGFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,669 in 135 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $3,757 · 2025 $3,669
Food & beverage: $3,594Education: $74
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $778 |
| Teva Pharmaceuticals USA, Inc. | 16 | $565 |
| E.R. Squibb & Sons, L.L.C. | 22 | $534 |
| Alkermes, Inc. | 21 | $387 |
| Vanda Pharmaceuticals Inc. | 13 | $362 |
| Janssen Pharmaceuticals, Inc | 12 | $359 |
| Axsome Therapeutics, Inc. | 5 | $234 |
| Neurocrine BioSciences, Inc. | 10 | $197 |
| Lundbeck LLC | 7 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
Products named: REXULTI, COBENFY, AUSTEDO XR, ARISTADA, Auvelity, HETLIOZ, INVEGA SUSTENNA, INGREZZA.
Industry payments across OH — which companies pay providers there.
